FORMULATIONS D'AGONISTE DES RÉCEPTEURS DE TYPE TOLL ET LEUR UTILISATION

• 收藏
• 分享

专利权人:

INC.;VENTIRX PHARMACEUTICALS

发明人:

申请号：

EP09803657.7

公开号：

EP2313111B1

申请日:

2009.07.31

申请国别(地区):

EP

年份:

2013

代理人:

摘要：

The present invention is directed generally to stable formulations of a TLR agonist preferably a TLR7 or a TLR8 agonist, for use in the treatment of cancer, preferably solid tumors and lymphomas. Specifically, the present invention is directed to stable formulations of up to 50 mg/ml of a TLR agonist which comprise a cyclodextrin.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/